Prevalence pattern and associations of migraine headaches in multiple sclerosis: Insights from a large-scale cross-sectional study
Abstract
BACKGROUND/AIM
While the comorbidity of migraine and multiple sclerosis (MS) has been documented, large-scale studies examining migraine patterns in MS patients, particularly across diverse age ranges, are scarce. This study aimed to evaluate the prevalence and patterns of migraines in MS patients and compare them with known patterns in the general population from existing literature.
METHODS
This cross-sectional study included 706 MS patients (ages 14-73), spanning pediatric to late-onset MS cases. Descriptive statistics, chi-square tests, and logistic regression were used to analyze the relationships between variables and identify factors influencing the risk of migraines.
RESULTS
Of the 706 patients, 185 (26.2%) were found to have migraines. Among these, 144 patients (77.8%) reported developing migraines after their MS diagnosis. Age and sex did not emerge as significant predictors of migraine prevalence. However, a notable association was observed between MS subtypes and migraine occurrence. Patients with the Relapsing-Remitting MS subtype had higher odds of experiencing migraines (odds ratio = 1.73, 95% CI: 1.03 to 2.89, p = 0.03), as did those with the Primary Progressive MS subtype (odds ratio = 2.48, 95% CI: 1.23 to 4.99, p = 0.01) compared to the Secondary Progressive subtype.
CONCLUSION
Our study highlights distinct patterns of migraine prevalence in MS patients, notably the lack of significant sex- or age-related differences, which contrasts with the established…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 706 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.